Prostate cancer comes in all kinds of varieties, from serious and life-threatening cases all the way to the more common, nonaggressive forms that are typically age related. The disease tends to occur ...

Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, ...

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said. Active surveillance has been shown to be an effective management strategy for ...

Please provide your email address to receive an email when new articles are posted on . Urologists more often recommend active surveillance over treatment for low-risk prostate cancer. Patients’ ...

Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of ...

A cancer diagnosis is serious, but immediately starting treatment sometimes isn't the best course of action. ljubaphoto/E+ via Getty Images Although about 1 in 8 men in the U.S. will be diagnosed with ...

Advances in technology have made active surveillance in men with prostate cancer possible and prevented treatment for men who don’t need it, said Matthew Nielsen, MD, FACS, chair, Department of ...

Please provide your email address to receive an email when new articles are posted on . Results refute criticisms about “losing a window of curability when delaying treatment.” Researchers estimated ...

Credit: Thinkstock Investigators report beneficial effects of aerobic high-intensity training on cardiometabolic biomarkers. Men on active surveillance for prostate cancer who participated in aerobic ...

Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to a new study. “Overtreatment of ...

Real-world data do not support discontinuing prostate cancer active surveillance for radical treatment without clear evidence of progression. Real-world data show that discontinuing prostate cancer ...

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...